NCT07088380 Ketamine Augmentation of ECT in Treatment-Resistant Depression Status RECRUITING Phase PHASE3
NCT07076407 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) Status RECRUITING Phase PHASE3
NCT07051746 Effectiveness of Traditional Chinese Metacognitive Training (MCT) in Patients With Schizophrenia, Depression, or Bipolar Disorder Attending a Psychiatric Day Hospital in Taiwan Status COMPLETED Phase NA
NCT07028216 Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method Status RECRUITING Phase NA
NCT07002684 Metabolic Profiling of Esketamine Treatment in Depressive Disorder Status RECRUITING Phase N/A
NCT06979154 Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS) Status RECRUITING Phase NA
NCT06976840 Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments Status RECRUITING Phase NA
NCT06966401 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) Status RECRUITING Phase PHASE3
NCT06964711 GW117 ODT (Orally Disintegrating Tablets) Safety and Pharmacokinetics Study in Healthy Subjects Status COMPLETED Phase PHASE1
NCT06963021 NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) Status RECRUITING Phase PHASE3
NCT06961851 Feasibility Pilot of Accelerated Stimulation With TMS for Treatment of Major Depressive Disorder (FAST-MDD) Status COMPLETED Phase EARLY_PHASE1
NCT06941844 A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06922110 An Open-Label Study of Azetukalner in Major Depressive Disorder Status ENROLLING_BY_INVITATION Phase PHASE3
NCT06911112 NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) Status RECRUITING Phase PHASE3